FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140237248> ?p ?o ?g. }

• W2140237248 endingPage "10044" @default.
• W2140237248 startingPage "10040" @default.
• W2140237248 abstract "To evaluate the effectiveness of ginsenoside Rg3 alone or in combination with cyclophosphamide (CPA) on tumor growth and angiogenesis in human lung cancer, 54 female athymic mice were transplanted with lung cancer cells (A549) which then were randomly divided into 4 groups: Ginsenoside Rg3 group, CPA group, ginsenoside Rg3 plus CPA group and control group. Ginsenoside Rg3 of 3.0 mg/kg (once/day for 10 days) and CPA of 20.0 mg/kg (once/day for 10 days) were intraperitoneally given to mice for consecutive 10 days. Seven mice selected from each group were sacrificed 18 days later. The survival time of the remaining 7 mice in each group was recorded. The life elongation rate, proliferating cell nuclear antigen labeling index (PCNALI), expression of vascular endothelial cell growth factor (VEGF) and microvessel density (MVD) in the tumor tissues were evaluated. The quality of life of mice with administration of ginsenoside Rg3 alone or ginsenoside Rg3 plus CPA were better with longer survival time, when compared with other groups. The PCNALI, MVD and VEGF expression in mice of the treated groups were significantly lowered when compared with that of the control group. Additionally, the MVD of mice in groups with treatment of ginsenoside Rg3 alone or ginsenoside Rg3 plus CPA were lower than that in the CPA group. Tumor growth and angiogenesis in lung cancer were profoundly inhibited by ginsenoside Rg3 alone or in combination with CPA. The synergistic anticancer effects of ginsenoside Rg3 and CPA improved the survival time in lung cancer.   Key words: Ginseng, cyclophosphamide, angiogenesis, lung cancer." @default.
• W2140237248 created "2016-06-24" @default.
• W2140237248 creator A5014564184 @default.
• W2140237248 creator A5015453811 @default.
• W2140237248 creator A5022023489 @default.
• W2140237248 creator A5027936438 @default.
• W2140237248 creator A5042241049 @default.
• W2140237248 creator A5042866937 @default.
• W2140237248 creator A5058291336 @default.
• W2140237248 creator A5078233673 @default.
• W2140237248 creator A5086275760 @default.
• W2140237248 date "2011-08-31" @default.
• W2140237248 modified "2023-10-01" @default.
• W2140237248 title "Synergistic effects of ginsenoside Rg3 and cyclophosphamine on tumor growth and angiogenesis in lung cancer" @default.
• W2140237248 cites W1495803526 @default.
• W2140237248 cites W195439006 @default.
• W2140237248 cites W1996852003 @default.
• W2140237248 cites W2004249321 @default.
• W2140237248 cites W2006148921 @default.
• W2140237248 cites W2007793189 @default.
• W2140237248 cites W2007845211 @default.
• W2140237248 cites W2029883816 @default.
• W2140237248 cites W2059294866 @default.
• W2140237248 cites W2086528927 @default.
• W2140237248 cites W2107139417 @default.
• W2140237248 cites W2107211438 @default.
• W2140237248 cites W2123304308 @default.
• W2140237248 cites W2170781836 @default.
• W2140237248 cites W2172126351 @default.
• W2140237248 cites W2269924793 @default.
• W2140237248 cites W2365891201 @default.
• W2140237248 cites W2411323556 @default.
• W2140237248 cites W349819525 @default.
• W2140237248 doi "https://doi.org/10.5897/ajb11.829" @default.
• W2140237248 hasPublicationYear "2011" @default.
• W2140237248 type Work @default.
• W2140237248 sameAs 2140237248 @default.
• W2140237248 citedByCount "5" @default.
• W2140237248 countsByYear W21402372482013 @default.
• W2140237248 countsByYear W21402372482015 @default.
• W2140237248 countsByYear W21402372482016 @default.
• W2140237248 countsByYear W21402372482018 @default.
• W2140237248 crossrefType "journal-article" @default.
• W2140237248 hasAuthorship W2140237248A5014564184 @default.
• W2140237248 hasAuthorship W2140237248A5015453811 @default.
• W2140237248 hasAuthorship W2140237248A5022023489 @default.
• W2140237248 hasAuthorship W2140237248A5027936438 @default.
• W2140237248 hasAuthorship W2140237248A5042241049 @default.
• W2140237248 hasAuthorship W2140237248A5042866937 @default.
• W2140237248 hasAuthorship W2140237248A5058291336 @default.
• W2140237248 hasAuthorship W2140237248A5078233673 @default.
• W2140237248 hasAuthorship W2140237248A5086275760 @default.
• W2140237248 hasBestOaLocation W21402372481 @default.
• W2140237248 hasConcept C121608353 @default.
• W2140237248 hasConcept C126322002 @default.
• W2140237248 hasConcept C142724271 @default.
• W2140237248 hasConcept C167734588 @default.
• W2140237248 hasConcept C204787440 @default.
• W2140237248 hasConcept C2776256026 @default.
• W2140237248 hasConcept C2776539398 @default.
• W2140237248 hasConcept C2776694085 @default.
• W2140237248 hasConcept C2776755627 @default.
• W2140237248 hasConcept C2777025900 @default.
• W2140237248 hasConcept C2779232237 @default.
• W2140237248 hasConcept C2780394083 @default.
• W2140237248 hasConcept C71924100 @default.
• W2140237248 hasConcept C98274493 @default.
• W2140237248 hasConceptScore W2140237248C121608353 @default.
• W2140237248 hasConceptScore W2140237248C126322002 @default.
• W2140237248 hasConceptScore W2140237248C142724271 @default.
• W2140237248 hasConceptScore W2140237248C167734588 @default.
• W2140237248 hasConceptScore W2140237248C204787440 @default.
• W2140237248 hasConceptScore W2140237248C2776256026 @default.
• W2140237248 hasConceptScore W2140237248C2776539398 @default.
• W2140237248 hasConceptScore W2140237248C2776694085 @default.
• W2140237248 hasConceptScore W2140237248C2776755627 @default.
• W2140237248 hasConceptScore W2140237248C2777025900 @default.
• W2140237248 hasConceptScore W2140237248C2779232237 @default.
• W2140237248 hasConceptScore W2140237248C2780394083 @default.
• W2140237248 hasConceptScore W2140237248C71924100 @default.
• W2140237248 hasConceptScore W2140237248C98274493 @default.
• W2140237248 hasIssue "49" @default.
• W2140237248 hasLocation W21402372481 @default.
• W2140237248 hasOpenAccess W2140237248 @default.
• W2140237248 hasPrimaryLocation W21402372481 @default.
• W2140237248 hasRelatedWork W2013205981 @default.
• W2140237248 hasRelatedWork W2181959917 @default.
• W2140237248 hasRelatedWork W2264827465 @default.
• W2140237248 hasRelatedWork W2327947864 @default.
• W2140237248 hasRelatedWork W2354240765 @default.
• W2140237248 hasRelatedWork W2792615657 @default.
• W2140237248 hasRelatedWork W3029919179 @default.
• W2140237248 hasRelatedWork W4294939438 @default.
• W2140237248 hasRelatedWork W4297905053 @default.
• W2140237248 hasRelatedWork W4367294829 @default.
• W2140237248 hasVolume "10" @default.
• W2140237248 isParatext "false" @default.
• W2140237248 isRetracted "false" @default.

• next